Metronidazole Extended Release Tablets USP 600mg – Pretogyl Tablets

PRETOGYL Tablets
Composition:- Metronidazole 600mg Extended Release

Pretogyl Tablets – Metronidazole Extended Release Tablets USP is a nitroimidazole-class antimicrobial agent with both antiprotozoal and antibacterial effects. It disrupts DNA synthesis in anaerobic organisms and protozoa, leading to cell death. The sustained-release (SR) formulation ensures prolonged activity, reducing the need for frequent dosing, particularly beneficial in chronic infections such as amoebiasis or bacterial vaginosis.

Key Points of Metronidazole Extended Release Tablets – PRETOGYL Tablets
• Sustained-Release for Better Compliance – Once or twice daily dosing maintains consistent therapeutic levels, enhancing patient adherence in chronic infections.
• Effective against Anaerobic & Antiprotozoal both – Effective against Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis, and anaerobic bacteria like Bacteroides.
• Reduces Recurrence & Resistance Risk – Extended exposure reduces bacterial load and helps prevent treatment failure or resistance.

Can be Prescribed by:
• General Physicians
• Gastroenterologists
• Gynecologists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.